Recombinant Spike Rbd

Lab Reagents

Human IgG antibody Laboratories manufactures the recombinant spike rbd reagents distributed by Genprice. The Recombinant Spike Rbd reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike RBD. Other Recombinant products are available in stock. Specificity: Recombinant Category: Spike Group: Rbd

Rbd information

SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein
20-232 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein

Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant
P1530-10 10 µg
EUR 187.2

Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant
P1530-50 50 µg
EUR 709.2

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His]
VAng-Wyb7338-100g 100 µg
EUR 2096.4
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His]
VAng-Wyb7338-20g 20 µg
EUR 753.6
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His]
VAng-Wyb7338-50g 50 µg
EUR 1326
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc]
VAng-Wyb7339-100g 100 µg
EUR 2096.4
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc]
VAng-Wyb7339-20g 20 µg
EUR 753.6
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc]
VAng-Wyb7339-50g 50 µg
EUR 1326
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

SARS-CoV-2 (COVID-19) Spike RBD + SD1 +SD2 Recombinant Protein
10-305 0.1 mg
EUR 632.4
Description: SARS-CoV-2 (COVID-19) Spike RBD + SD1 +SD2 Recombinant Protein

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; RBD), Recombinant
P1529-10 10 µg
EUR 235.2

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; RBD), Recombinant
P1529-50 50 µg
EUR 709.2

SARS-CoV-2 (COVID-19) Spike RBD Antibody (biotin)
9087-biotin-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike RBD Antibody (biotin)
9087-biotin-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 Spike RBD protein antibody pair 1
CSB-EAP33245 1 pair
EUR 900
Description: This is a set of capture antibody and HRP-conjugated antbody for quantitative detection of SARS-CoV-2 Spike RBD protein for through solid phase sandwich ELISA.

SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein
21-829 0.1 mg
EUR 714.3
Description: SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein

Human CellExp™ SARS-CoV-2 Spike Protein (RBD 310-568), Recombinant
P1543-10 10 µg
EUR 187.2